1. A practical approach to risk assessment to prevent coronary artery disease and its complications. Linton MF, Fazio S, National Cholesterol Education Program (NCEP)- the third Adult Treatment Panel (ATP III) (2003) Am J Cardiol 92(1A): 19i-26i
    › Primary publication · 12867251 (PubMed)
  2. Apolipoprotein AI as therapy for atherosclerosis: does the future of preventive cardiology include weekly injections of the HDL protein? Fazio S, Linton MF (2003) Mol Interv 3(8): 436-40
    › Primary publication · 14993451 (PubMed)
  3. Retroviral mediated expression of the human myeloid nuclear antigen in a null cell line upregulates Dlk1 expression. Doggett KL, Briggs JA, Linton MF, Fazio S, Head DR, Xie J, Hashimoto Y, Laborda J, Briggs RC (2002) J Cell Biochem 86(1): 56-66
    › Primary publication · 12112016 (PubMed)
  4. Rapid quantification of murine ABC mRNAs by real time reverse transcriptase-polymerase chain reaction. Su YR, Linton MF, Fazio S (2002) J Lipid Res 43(12): 2180-7
    › Primary publication · 12454281 (PubMed)
  5. Physiological expression of macrophage apoE in the artery wall reduces atherosclerosis in severely hyperlipidemic mice. Fazio S, Babaev VR, Burleigh ME, Major AS, Hasty AH, Linton MF (2002) J Lipid Res 43(10): 1602-9
    › Primary publication · 12364544 (PubMed)
  6. Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis. Boord JB, Fazio S, Linton MF (2002) Curr Opin Lipidol 13(2): 141-7
    › Primary publication · 11891416 (PubMed)
  7. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. Burleigh ME, Babaev VR, Oates JA, Harris RC, Gautam S, Riendeau D, Marnett LJ, Morrow JD, Fazio S, Linton MF (2002) Circulation 105(15): 1816-23
    › Primary publication · 11956125 (PubMed)
  8. Cyclooxygenase-2 and atherosclerosis. Linton MF, Fazio S (2002) Curr Opin Lipidol 13(5): 497-504
    › Primary publication · 12352013 (PubMed)
  9. B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Major AS, Fazio S, Linton MF (2002) Arterioscler Thromb Vasc Biol 22(11): 1892-8
    › Primary publication · 12426221 (PubMed)
  10. Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia. Boord JB, Maeda K, Makowski L, Babaev VR, Fazio S, Linton MF, Hotamisligil GS (2002) Arterioscler Thromb Vasc Biol 22(10): 1686-91
    › Primary publication · 12377750 (PubMed) · PMC4027051 (PubMed Central)